#oncology

- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...

- The Lien Foundation calls on governments and policy makers to hasten and improve their provision of palliative ...

- Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune in ...

based companion diagnostic (CDx) in immuno-oncologyDARMSTADT, Germany & NEW YORK--(Antara/BUSINESS WIRE.

- Pathway Genomics, a global precision medical diagnostics company, announced the launch of ...

- Nine out of 10 physicians in Asia-Pacific use some form of online search to aid clinical decision-making, with ...

- Vinmec International Hospital here in Hanoi has commenced offering cancer patients advanced radiotherapy with a new ...

NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205- PEA PME eligible), a clinical-stage nanomedicine company pioneering ...

- Takeda Pharmaceuticals International GmbH ("Takeda") today announced that Giles Platford has been appointed Head of ...

- Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung ...

- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its new FLOW system for use with Laboratory ...

- On September 3, 2013, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. officially signed a strategic cooperation ...

- On September 3, 2013, Shanghai Fosun Pharmaceutical (Group) Co., Ltd purchased a 50% stake in Guangzhou Nanyang ...

- Transaction Designed to Enhance Shareholder Value By Unlocking Value of the Epigenetics Platform- TSX Exchange ...

- In conjunction with the inauguration of the Gamma Knife® Center Indonesia, Siloam International Hospitals Lippo ...